Background/Aims: Anthocyanins are plant-derived dietary components that are highly abundant, for example, in bilberries. We have previously demonstrated that anthocyanins exert anti-inflammatory properties in mouse colitis models and ameliorate disease activity in ulcerative colitis patients. Here, we studied the molecular mechanisms through which anthocyanin-containing bilberry extract (BE) exerts anti-inflammatory effects in human monocytic THP-1 cells. Methods: THP-1 cells were pre-incubated with BE 20 min prior to TNF-a or IFN-γ (100 ng/ml each) stimulation. Signalling protein activation was studied by Western blotting, mRNA expression by quantitative PCR and cytokine secretion by ELISA. Results: IFN-γ-induced phosphorylation of STAT1 and STAT3 was significantly reduced by BE co-treatment. Consequently, levels of mRNA expression and/or cytokine secretion of MCP-1, IL-6, TNF-a, ICAM-1, and T-bet were lower with BE co-treatment. In contrast, BE enhanced TNF-a-mediated p65-NF-γB phosphorylation but reduced ERK1/2 phosphorylation. BE co-treatment further increased TNF-a-induced mRNA expression and secretion of NF-γB target genes, such as IL-6, IL-8, and MCP-1, while mRNA levels of ICAM-1 were reduced. Conclusions: BE co-treatment reduced IFN-γ-induced signal protein activation, pro-inflammatory gene expression, and cytokine secretion, whereas it enhanced TNF-a-induced responses. These findings suggest a distinct role for anthocyanins in modulating inflammatory responses that need to be further studied to fully understand anthocyanin-mediated effects.

1.
Crozier A, Jaganath IB, Clifford MN: Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 2009;26:1001-1043.
[PubMed]
2.
Cardona F, Andrés-Lacueva C, Tulipani S, et al: Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem 2013;24:1415-1422.
[PubMed]
3.
Scalbert A, Williamson G: Dietary intake and bioavailability of polyphenols. J Nutr 2000;130:2073S-2085S.
[PubMed]
4.
Jennings A, Welch AA, Fairweather-Tait SJ, et al: Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin Nutr 2012;96:781-788.
[PubMed]
5.
Hooper L, Kay C, Abdelhamid A, et al: Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 2012;95:740-751.
[PubMed]
6.
Serra D, Paixão J, Nunes C, et al: Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic acid. PLoS One 2013;8:e73001.
[PubMed]
7.
Mauray A, Felgines C, Morand C, et al: Nutrigenomic analysis of the protective effects of bilberry anthocyanin-rich extract in apo E-deficient mice. Genes Nutr 2010;5:343-353.
[PubMed]
8.
Chu W, Cheung SCM, Lau RAW, Benzie IFF: Bilberry (Vaccinium myrtillus L.); in Benzie IFF, Wachtel-Galor S (eds): Herbal Medicine: Biomolecular and Clinical Aspects. Boca Raton, CRC Press, 2011, pp 55-72. http://www.ncbi.nlm.nih.gov/books/NBK92770/.
[PubMed]
9.
Chen J, Uto T, Tanigawa S, et al: Expression profiling of genes targeted by bilberry (Vaccinium myrtillus) in macrophages through DNA microarray. Nutr Cancer 2008;60(suppl 1):43-50.
[PubMed]
10.
Triebel S, Trieu HL, Richling E: Modulation of inflammatory gene expression by a bilberry (Vaccinium myrtillus L.) extract and single anthocyanins considering their limited stability under cell culture conditions. J Agric Food Chem 2012;60:8902-8910.
[PubMed]
11.
Osman N, Adawi D, Ahrné S, et al: Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis. Dig Dis Sci 2008;53:2464-2473.
[PubMed]
12.
Piberger H, Oehme A, Hofmann C, et al: Bilberries and their anthocyanins ameliorate experimental colitis. Mol Nutr Food Res 2011;55:1724-1729.
[PubMed]
13.
Wu LH, Xu ZL, Dong D, et al: Protective effect of anthocyanins extract from blueberry on TNBS-induced IBD model of mice. Evid Based Complement Alternat Med 2011;2011:525462.
[PubMed]
14.
Biedermann L, Mwinyi J, Scharl M, et al: Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - an open pilot study. J Crohns Colitis 2013;7:271-279.
[PubMed]
15.
Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434.
[PubMed]
16.
Cho JH: The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008;8:458-466.
[PubMed]
17.
Khor B, Gardet A, Xavier RJ: Genetics and pathogenesis of inflammatory bowel disease. Nature 2011;474:307-317.
[PubMed]
18.
Orholm M, Binder V, Sørensen TI, et al: Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000;35:1075-1081.
[PubMed]
19.
Halfvarson J, Bodin L, Tysk C, et al: Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003;124:1767-1773.
[PubMed]
20.
Thompson NP, Driscoll R, Pounder RE, et al: Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 1996;312:95-96.
[PubMed]
21.
Binder V: Genetic epidemiology in inflammatory bowel disease. Dig Dis 1998;16:351-355.
[PubMed]
22.
Cho JH: Inflammatory bowel disease: genetic and epidemiologic considerations. World J Gastroenterol 2008;14:338-347.
[PubMed]
23.
Kobayashi KS, Chamaillard M, Ogura Y, et al: Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005;307:731-734.
[PubMed]
24.
Hedl M, Li J, Cho JH, et al: Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci USA 2007;104:19440-19445.
[PubMed]
25.
Economou M, Trikalinos TA, Loizou KT, et al: Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004;99:2393-2404.
[PubMed]
26.
Duerr RH, Taylor KD, Brant SR, et al: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-1463.
[PubMed]
27.
Hampe J, Franke A, Rosenstiel P, et al: A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007;39:207-211.
[PubMed]
28.
Feagan BG, Macdonald JK: Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2012;10:CD000544.
[PubMed]
29.
Coskun M, Salem M, Pedersen J, et al: Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res 2013;76:1-8.
[PubMed]
30.
Blouin CM, Lamaze C: Interferon gamma receptor: the beginning of the journey. Front Immunol 2013;4:267.
[PubMed]
31.
Gough DJ, Levy DE, Johnstone RW, et al: IFNgamma signalling - does it mean JAK-STAT? Cytokine Growth Factor Rev 2008;19:383-394.
[PubMed]
32.
Hu X, Ivashkiv LB: Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009;31:539-550.
[PubMed]
33.
Musso A, Dentelli P, Carlino A, et al: Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation. Inflamm Bowel Dis 2005;11:91-98.
[PubMed]
34.
Schreiber S, Rosenstiel P, Hampe J, et al: Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 2002;51:379-385.
[PubMed]
35.
Li Y, de Haar C, Peppelenbosch MP, et al: New insights into the role of STAT3 in IBD. Inflamm Bowel Dis 2012;18:1177-1183.
[PubMed]
36.
Yoshioka K: Scaffold proteins in mammalian MAP kinase cascades. J Biochem 2004;135:657-661.
[PubMed]
37.
Chen Z, Gibson TB, Robinson F, et al: MAP kinases. Chem Rev 2001;101:2449-2476.
[PubMed]
38.
Broom OJ, Widjaya B, Troelsen J, et al: Mitogen activated protein kinases: a role in inflammatory bowel disease? Clin Exp Immunol 2009;158:272-280.
[PubMed]
39.
Scaldaferri F, Sans M, Vetrano S, et al: The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. Eur J Immunol 2009;39:290-300.
[PubMed]
40.
Roy PK, Rashid F, Bragg J, et al: Role of the JNK signal transduction pathway in inflammatory bowel disease. World J Gastroenterol 2008;14:200-202.
[PubMed]
41.
Waetzig GH, Seegert D, Rosenstiel P, et al: p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol 2002;168:5342-5351.
[PubMed]
42.
Rasheed Z, Akhtar N, Anbazhagan AN, et al: Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells. J Inflamm (Lond) 2009;6:1.
[PubMed]
43.
Ueda A, Okuda K, Ohno S, et al: NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994;153:2052-2063.
[PubMed]
44.
Libermann TA, Baltimore D: Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990;10:2327-2334.
[PubMed]
45.
Kunsch C, Rosen CA: NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 1993;13:6137-6146.
[PubMed]
46.
Vanden Berghe W, Vermeulen L, De Wilde G, et al: Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem Pharmacol 2000;60:1185-1195.
[PubMed]
47.
Rogler G, Brand K, Vogl D, et al: Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998;115:357-369.
[PubMed]
48.
Min SW, Ryu SN, Kim DH: Anti-inflammatory effects of black rice, cyanidin-3-O-beta-D-glycoside, and its metabolites, cyanidin and protocatechuic acid. Int Immunopharmacol 2010;10:959-966.
[PubMed]
You do not currently have access to this content.